Skip to main content

Endovia Health Sciences, Inc.

EDVA
Exchange
NYSE
Industry
Beverages
SEC CIK
0001553788

No open-market purchases or sales by Endovia Health Sciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $172.1K in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Endovia Health Sciences, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of EDVA: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders2628+2
Shares2.62M2.72M+102.9K (+3.9%)
Value$2.93M$1.61M−$1.32M (−45.1%)

New holders (6)

Institutions that held Endovia Health Sciences, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to EDVA in Q3 2023
InstitutionSharesValue% of portfolio
Steward Partners Investment Advisory, LLC146,250$86.3K0.00%
LGT Financial Advisors LLC96,741$57.1K0.07%
Wealth Enhancement Advisory Services, LLC60,075$35.4K0.00%
Jane Street Group, LLC13,617$8.03K0.00%
StoneX Group Inc.13,152$7.76K0.00%
JPMorgan Chase & Co35$210.00%

Sold out (4)

Institutions that held Endovia Health Sciences, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of EDVA in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Commonwealth Equity Services, LLC128,250$144.0K
Two Sigma Securities, LLC36,094$40.4K
FNY Investment Advisers, LLC32,500$36.0K
UBS Group AG900$1.01K